SAN FRANCISCO, Dec. 4, 2013 /PRNewswire/ -- goBalto, Inc. announced today the appointment of Sujay Jadhav as Chief Executive Officer. Jae Chung, former CEO and founder, will manage corporate strategy, sales, and business development as President.
This appointment positions goBalto for accelerated sales in domestic markets and globally. With an increasing customer base in top pharma and CROs, and planned expansion into international markets, Jadhav's experience integrating software development, life sciences, and corporate strategy is ideally suited to help strengthen goBalto's market leadership.
Most recently, Jadhav was Senior VP of Global Corporate Strategy and Development at Model N, where he led corporate development and life sciences, analytics, and SaaS business units. He was employee #6 and instrumental in the growth of Model N to 600 employees, over $100M in revenue, and its eventual IPO (NYSE: MODN). His career includes strategy consulting at Booz Allen Hamilton, product strategy at CommerceOne, and general management at Singapore Telecom.
Jadhav received his undergraduate degree from the University of South Australia and an MBA from Harvard Business School.
"I'm honored and delighted to lead goBalto into becoming a recognized global brand. This is a unique opportunity to transform an industry through technology. goBalto's talented team and groundbreaking product are poised to make a difference, and I'm excited to grow the company into a market leader," said Jadhav.
"I founded goBalto 5 years ago on the principle that the life sciences industry should not accept the status quo in how clinical studies are started," said Chung. "Our vision has resonated with numerous leading biopharmaceutical companies and CROs, resulting in strong demand for our cloud-based solution – Tracker 2.0. I'm pleased Sujay is joining team goBalto as our CEO. With Sujay at the helm, I know we'll grow into a world-class solutions provider to tackle the complex terrain of clinical study startup and beyond."
goBalto develops next-generation solutions that simplify how clinical trials are started in the pharmaceutical, biotechnology, and medical device industries. Our flagship product, Tracker, is a purpose-built software-as-a-service clinical research platform. It enables clinical trial sponsors and research organizations to track milestones on the critical path, and provides document workflow management capabilities in a transparent, regulatory-compliant, and user-friendly way. Founded in 2008 in Silicon Valley by biotechnology industry veteran Jae Chung, goBalto is backed by leading health technology investors. For more information, visit www.gobalto.com.
Contact: Maria Breaux, 415-994-5040, firstname.lastname@example.org
|SOURCE goBalto, Inc.|
Copyright©2012 PR Newswire.
All rights reserved